Management of thyroid carcinoma relies upon the tumour cells maintaining the differentiated
functions that are typical of normal thyroid follicular cells, such as: dependence upon …

Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

Thyroid cancer is the most common endocrine malignancy, although representing fewer
than 1% of all human tumors. Differentiated thyroid carcinoma (DTC) includes the papillary …

Background: The management of thyroid cancer is difficult because the tumors comprise a
wide range of biologic behaviors, from small papillary thyroid microcarcinomas that pose …

Spectrum of Behavior.-The clinical behavior of well-differentiated-papillary and follicular-
thyroid carcinoma has become increasingly clearer in recent years. Almost all physicians …

Derived from follicular epithelial cells, differentiated thyroid cancer (DTC) accounts for the
majority of thyroid malignancies. The threefold increase in DTC incidence over the last three …

The spectrum of human thyroid cancer includes both indolent differentiated neoplasms and
highly virulent, rapidly fatal anaplastic carcinoma. The majority of thyroid carcinomas (about …

Designing a medically appropriate, cost-effective means of evaluating patients with nodular
thyroid disease is a common clinical problem, especially as sensitive ultrasound is revealing …

Although thyroid cancer represents less than 1% of malignant tumours, its increased
incidence detected in recent years and the appearance and development of new drugs …

The concept of individualized therapy is rapidly gaining recognition in the management of
patients with differentiated thyroid cancer (DTC). This Review provides an overview of the …